AKT1 and thyroid cancer: Regarding targeting BRAF mutant thyroid cancer cells, it was shown that vitamin C plays its antitumour effect through inhibition of MAPK/ERK and PI3K/AKT pathway which was mediated by ROS‐dependent manner.20